DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Murepavadin
Murepavadin
Jonathan Butcher, Polyphor, Switzerland
IX Updating Course of Antimicrobials and Infectious Diseases
Clinical Isolates of Extensively Drug-Resistant
Periodic Project Report Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Iabc
Balixafortide Execution and Pipeline Expansion
Β-Hairpin Antimicrobial Peptides
Novel Role of Pseudomonas Aeruginosa Lptd Operon Sundar Pandey
[email protected]
Antimicrobial Activity of Murepavadin Tested Against Clinical Isolates of Pseudomonas Aeruginosa Helio S
Clinical Isolates of Extensively Drug-Resistant (XDR) Pseudomona
Omptas: Outer Membrane Protein Targeting Antibiotics Antibiotic Guardian Conference June 27Th, 2018 in London, United Kingdom
VIII Updating Course of Antimicrobials and Infectious Disesaes
Antibiotics Currently in Global Clinical Development Note: This Data Visualization Was Updated in March 2019 with New Data
Novel Insights Into the Connection Between Peptidoglycan Recycling and Multidrug Resistance in Pseudomonas Aeruginosa
FDA Briefing Document Developing Antibacterial Therapies Targeting A
Bacterial Nosocomial Infections: Multidrug Resistance As a Trigger for the Development of Novel Antimicrobials
2019 Antibacterial Agents in Clinical Development
Clinical Isolates of Extensively Drug-Resistant (XDR) Pseudomonas Aeruginosa
Polyphor: Pioneering the Development of "OMPTA", Potentially the First New Class of Antibiotics to Be Introduced Against Gram Negative Bacteria in ~50 Years
Top View
Chimeric Peptidomimetic Antibiotics Against Gram-Negative Bacteria
Chem. Pharm. Bull. 68(3): 182-190 (2020)
Antibiotics in the Clinical Pipeline in October 2019
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Annual Activity Report 2018
Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria
Public Workshop March 1, 2017
Q&A Session POLYPHOR
ESCMID Elibrary © by Author
The Clinical Potential of Antimicrobial Peptides
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-To-Treat Resistance
Antimicrobial Resistance in ESKAPE Pathogens
Synthesis and Antimicrobial Activity of Β-Hairpin Peptidomimetics Against Pseudomonas Aeruginosa